Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer

被引：0
|
作者：
Yuqi Jiang
Jing Wang
Peng Jiang
Xiang Wang
Lei Zhang
Yongchun Zhang
机构：
[1] The Affiliated Hospital of Qingdao University,Department of Radiation Oncology
来源：
BMC Cancer | / 23卷
关键词：
Uterine cervical neoplasms; Neoplasm recurrence; Intensity modulated radiotherapy; Adverse effects; Simultaneous integrated boost intensity-modulated radiotherapy; High-risk CTV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Knowledge-Based Intensity-Modulated Radiotherapy Plans for Cervical Cancer with Overlap Volume of Target and Organs at Risk
    Ma, C.
    MEDICAL PHYSICS, 2018, 45 (06) : E437 - E437
  • [42] Clinical study of acute toxicity of pelvic bone marrow-sparing intensity-modulated radiotherapy for cervical cancer
    Sun, Shuangshaung
    Chen, Zhi
    Li, Pingping
    Wu, Jian
    Zhu, Baoling
    Zhang, Xi
    Wu, Congcong
    Lin, Ruifang
    Zhou, Yingying
    Chen, Wenjun
    GINEKOLOGIA POLSKA, 2023, 94 (02) : 101 - 106
  • [43] Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy
    Yamamoto, Takaya
    Umezawa, Rei
    Tokunaga, Hideki
    Kubozono, Masaki
    Kozumi, Maiko
    Takahashi, Noriyoshi
    Matsushita, Haruo
    Kadoya, Noriyuki
    Ito, Kengo
    Sato, Kiyokazu
    Tsuji, Keita
    Shimada, Muneaki
    Jingu, Keiichi
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (03) : 470 - 478
  • [44] Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa
    Cheng-Long Huang
    Rui Guo
    Jun-Yan Li
    Cheng Xu
    Yan-Ping Mao
    Li Tian
    Ai-Hua Lin
    Ying Sun
    Jun Ma
    Ling-long Tang
    European Radiology, 2020, 30 : 816 - 822
  • [45] Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa
    Huang, Cheng-Long
    Guo, Rui
    Li, Jun-Yan
    Xu, Cheng
    Mao, Yan-Ping
    Tian, Li
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    Tang, Ling-long
    EUROPEAN RADIOLOGY, 2020, 30 (02) : 816 - 822
  • [46] Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial
    Wang, X.
    Shen, Y.
    Zhao, Y.
    Li, Z.
    Gou, H.
    Cao, D.
    Yang, Y.
    Qiu, M.
    Li, Q.
    Liu, J.
    Yi, C.
    Liao, Z.
    Luo, D.
    Xu, F.
    Bi, F.
    EJSO, 2015, 41 (08): : 1082 - 1088
  • [47] Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
    Thomson, David
    Merrick, Sophie
    Swindell, Ric
    Coote, Joanna
    Kelly, Kay
    Stratford, Julie
    Wylie, James
    Cowan, Richard
    Elliott, Tony
    Logue, John
    Choudhury, Ananya
    Livsey, Jacqueline
    PROSTATE CANCER, 2012, 2012
  • [48] TOXICITY ASSESSMENT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO PROSTATE FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    McCammon, Robert
    Rusthoven, Kyle E.
    Kavanagh, Brian
    Newell, Sherri
    Newman, Francis
    Raben, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 413 - 420
  • [49] Phase I/II study of neoadjuvant docetaxel plus intensity-modulated radiotherapy (IMRT) prior to surgery for high-risk prostate cancer
    Garzotto, M.
    Hung, A.
    Beer, T. M.
    Alumkal, J. J.
    Graff, J. N.
    Farris, P. E.
    Fiamiatos, J. F.
    Mongoue-Tchokote, S.
    Carter, S. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma
    Park T.-K.
    Kwon J.-Y.
    Kim S.-W.
    Kim S.-H.
    Kim S.-N.
    Kim G.E.
    International Journal of Clinical Oncology, 2004, 9 (2) : 120 - 124
12345